Stock Research for IDXX

Get the due diligence for another stock.

IDXX Stock Chart & Research Data

The IDXX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the IDXX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.

IDXX Due diligence Resources & Stock Charts

The IDXX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

WESTBROOK, Maine, Jan. 21, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics and software, today announced that it is introducing a new canine progesterone test for Catalyst Dx® and Catalyst One® chemistry analyzers. This much-anticipated in-house diagnostic will help veterinarians determine when a dog is ready to breed by providing a reliable, quantitative, point-of-care measure of progesterone levels to ascertain ovulation status. IDEXX will begin shipping the new test by the end of March, with initial availability in the United States, Canada, the United Kingdom, France, Germany, and Austria, and will continue shipping to other countries over the course of 2019.

# Idexx Laboratories Inc
### NASDAQ/NGS:IDXX
View full report here!
## Summary
* ETFs holding this stock are seeing positive inflows but are weakening
* Bearish sentiment is low
## Bearish sentiment
Short interest | Positive
Short interest is extremely low for IDXX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX.
## Money flow
ETF/Index ownership | Negative
ETF activity is negative and may be weakening. The net inflows of $5.44 billion over the last one-month into ETFs that hold IDXX are among the lowest of the last year and appear to be slowing.
## Economic sentiment
PMI by IHS Markit | Neutral
According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, but is easing.
## Credit worthiness
Credit default swap
CDS data is not available for this security.
Please send all inquiries related to the report to score@ihsmarkit.com.
Charts and report PDFs will only be available for 30 days after publishing.
This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

The leader in veterinary diagnostics continued to report strong growth last year.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.

Research stock market information without several bookmarks at once.

General Information / Disclaimer

The resources and various material on this website are provided for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation or endorsement for any security or strategy, nor does it constitute an offer to provide investment advisory services by StockStatus. All copyrights belong to their respective owners. This website may contain hypertext links to other websites, which are completely independent of this site. StockStatus makes no representation or warranty as to the accuracy, completeness or authenticity of the information contained in any such hyperlink, and any hyperlink to another person or entity shall not in any manner be construed as endorsement by StockStatus of such person’s or entity’s website, products or services. The website offers no opinion with respect to the suitability of any security or specific investment and all investments involve risk, including loss of principal.